Drug Discovery

+

Synaptys neuroscience

Lilly Moran, 25 March, 2025, 0

Synaptys neuroscience An innovative approach against Alzheimer’s disease

+

Labsinlove SL

Lilly Moran, 20 March, 2025, 0

Labsinlove SL A New Hope for Poor-Prognosis Cancers with One-Day, Targeted Radiotherapy

+

AXOLTIS PHARMA

Lilly Moran, 27 February, 2025, 0

AXOLTIS PHARMA Potential revolution in the treatment of neurodegenerative diseases

+

SERVATRIX BIOMED

Lilly Moran, 29 January, 2025, 0

SERVATRIX BIOMED Innovative therapies for chronic liver diseases

+

Karla Therapeutics

Heidi Rohwer, 2 April, 2024, 0

Karla Therapeutics Harnessing the immune system to restore peace of mind Drug Discovery In vitro, proof of concept France 3.000.000€...

+

Mid-Atlantic BioTherapeutics

Heidi Rohwer, 26 June, 2023, 0

Mid-Atlantic BioTherapeutics A late-stage drug development company Drug Discovery Development, market readiness, clinical trial USA and EU holding will be...

+

Prospera Biotech

Antonio Ferrer, 3 January, 2023, 0

Prospera Biotech Innovative neurodermatological solutions to improve quality of life of cancer patients treated with chemotherapy Biotech Sales, licensing phases...

+

SJT Molecular

Antonio Exposito, 6 May, 2022, 0

SJT Molecular Family of molecules with oral therapeutic potential in NAFLD, NASH, obesity, hypertension and type 2 diabetes Drug Discovery...

+

Laminar Pharmaceuticals S.A.

Kaori Mutsuda Zapater, 1 April, 2022, 0

Laminar Pharmaceuticals S.A. The number One Biotech in Spain Drug Discovery Development, market readiness, clinical trial España 1.600.000€ Status Approved...

+

InnoUp Farma

Marc Sastre Capital Cell, 14 May, 2020, 0

InnoUp Farma Biopharmaceutical company in clinical phase that develops innovative nanomedicines for unmet medical needs. Drug Discovery Development, market...